Source-grounded facts extracted from INTEGRA LIFESCIENCES HOLDINGS CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Jan D. De Witte was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.
“the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment.”
Jan D. De Witte was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
“the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer”
Jan D. De Witte was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.
“the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment”
Jan D. De Witte was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
“On October 28, 2021, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.